Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene AlterationsJohn Tyhonas, Stephen W. Kaldor, Jason M. Cox et al.|Journal of Medicinal Chemistry|2024Cited by 18